The increase in FOXP3 expression may also explain the decrease of IL17 after Cr (III) treatment in this study due to the imbalance of the Treg/TH17 cytokine axis found in RA pathogenesis (Al-Zifzaf et al. 2015). This evidence concerns the gene FOXP3 and rheumatoid arthritis.